Sanofi Earnings Get Boost From Dupixent, New Drugs as U.S. Talks Continue

24 10 月, 2025

One Min Read

7 Views

原文: https://www.wsj.com/business/earnings/sanofi-earnings-driven-by-new-medicine-sales-dupixent-performance-8bf8970e?siteid=yhoof2&yptr=yahoo

Last Update: 24 10 月, 2025

Written By

Other Articles

Previous

《盤後部署》恒指收復兩萬六關惟受制於廿天線，人形機械人受惠國策優必選可吼

Next

港股收评：恒指涨0.74%，芯片半导体十分强势，券商股午后拉升明显

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept